Welcome to the fifth newsletter summarizing the latest clinical and real-world evidence in hypertension and reflecting on the clinical impact of these data on hypertension management.
Welcome to the fifth newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Watch the replay of our Satellite Symposium at ESC 2023 chaired by Mario Marzilli and Felicita Andreotti dedicated to ischaemic heart disease and including a patient perspective on the topic.
Welcome to the fourth newsletter summarizing the latest clinical and real-world evidence in hypertension and reflecting on the clinical impact of these data on hypertension management.
Welcome to the fourth newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Explore the retrospective, cross-sectional study describing the treatment patterns of Oral Glucose-Lowering Drugs in Asian population, using the JADE (Joint Asia Diabetes Evaluation) Register.
Welcome to the third newsletter summarizing the latest clinical and real-world evidence in hypertension and reflecting on the clinical impact of these data on hypertension management.
Welcome to the third newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Welcome to the second newsletter summarizing the latest clinical and real-world evidence in hypertension and reflecting on the clinical impact of these data on hypertension management.
